Amphastar Pharmaceuticals (AMPH) Interest Coverage Ratio: History & Chart

Amphastar Pharmaceuticals, Inc.(AMPH)

Drug Manufacturers - Specialty & Generic · Rancho Cucamonga, CA

$25.37-0.06 (-0.24%)

Delayed quote: Oct 5, 2026, 4:00 PM EDT

About Amphastar Pharmaceuticals, Inc.

Amphastar Pharmaceuticals, Inc., established in 1996 and based in Rancho Cucamonga, California, functions as a biopharmaceutical enterprise. The company is engaged in the creation, production, commercialization, and distribution of both generic and proprietary pharmaceutical products, which include injectables, inhalants, and intranasal formulations. Its market presence extends across the United States, China, and France. Amphastar's operations are divided into two primary segments: Finished Pharmaceutical Products and Active Pharmaceutical Ingredients (API). The company's extensive product portfolio encompasses a variety of crucial medications. These feature Primatene Mist, an over-the-counter epinephrine inhaler for the temporary alleviation of mild asthma symptoms; Enoxaparin, a low molecular weight heparin utilized for the prevention and treatment of deep vein thrombosis; and Naloxone, an essential treatment for opioid overdose. Other significant offerings include emergency Glucagon injection kits; Cortrosyn, a diagnostic agent for adrenocortical insufficiency; and Amphadase, a bovine-sourced hyaluronidase injection that aids in the absorption and dispersion of other administered drugs. Amphastar additionally supplies Epinephrine injections for severe allergic reactions; various lidocaine products (such as a jelly for urological procedures and a topical solution for other applications); Phytonadione injection (Vitamin K1) for newborns; and specialized emergency syringe products for hospital use. Furthermore, the company provides Morphine injections for patient-controlled analgesia and Lorazepam injections for surgical and medical procedures. More advanced therapeutics consist of Neostigmine methylsulfate injection to manage myasthenia gravis and reverse muscle relaxant effects, and Isoproterenol hydrochloride injection for mild or transient episodes of heart block. Beyond its finished pharmaceutical goods, Amphastar also acts as a distributor for recombinant human insulin API and porcine insulin API. The company caters to a broad spectrum of healthcare providers, including hospitals, various care facilities, clinics, and physicians' offices.

Rancho Cucamonga, CA

1,976 employees

www.amphastar.com

Healthcare / Drug Manufacturers - Specialty & Generic

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
CEO: Yongfeng Zhang

View full financials

AMPH Interest Coverage Ratio Metrics

INTEREST COVERAGE RATIO

5.51x

INTEREST COVERAGE RATIO AVG TTM

4.83x

INTEREST COVERAGE RATIO AVG 3Y

6.05x

INTEREST COVERAGE RATIO AVG 5Y

28.44x

INTEREST COVERAGE RATIO AVG 10Y

25.89x

INTEREST COVERAGE RATIO AVG 15Y

N/A

INTEREST COVERAGE RATIO AVG 20Y

N/A

CURRENT VS TTM AVG

+14.02%

CURRENT VS 3Y AVG

-8.94%

CURRENT VS 5Y AVG

-80.63%

CURRENT VS 10Y AVG

-78.72%

CURRENT VS 15Y AVG

N/A

CURRENT VS 20Y AVG

N/A

SECTOR MEDIAN · HEALTHCARE

-4.20x

median of 323 covered companies

CURRENT VS SECTOR MEDIAN

+231.19%

vs the sector median at left

NAME	MARKET CAP	INTEREST COVERAGE RATIO	TTM	3Y	5Y
Amphastar Pharmaceuticals, Inc. (AMPH)	$1.12B	5.51x	4.83x	6.05x	28.44x
Castle Biosciences, Inc. (CSTL)vs ›	$1.12B	-497.79x	15.03x	15.03x	8.31x
IRadimed Corporation (IRMD)vs ›	$1.11B	N/A	N/A	N/A	N/A
Bicara Therapeutics Inc. Common Stock (BCAX)vs ›	$1.14B	N/A	N/A	N/A	N/A
Harrow Health, Inc. (HROW)vs ›	$1.14B	1.60x	1.00x	0.57x	0.46x
GoodRx Holdings, Inc. (GDRX)vs ›	$1.16B	2.05x	1.65x	1.11x	0.98x
Teladoc Health, Inc. (TDOC)vs ›	$1.05B	-13.34x	N/A	N/A	N/A
Avalyn Pharma Inc. Common Stock (AVLN)vs ›	$1.20B	N/A	N/A	N/A	N/A
Immatics N.V. (IMTX)vs ›	$1.04B	-192.41x	28.86x	28.86x	28.86x
Integra LifeSciences Holdings Corporation (IART)vs ›	$1.03B	0.79x	0.59x	2.04x	2.37x

NAME

MARKET CAP

INTEREST COVERAGE RATIO

TTM

Amphastar Pharmaceuticals, Inc. (AMPH)

$1.12B

5.51x

4.83x

6.05x

28.44x

Castle Biosciences, Inc. (CSTL)vs ›

$1.12B

-497.79x

15.03x

8.31x

IRadimed Corporation (IRMD)vs ›

$1.11B

N/A

Bicara Therapeutics Inc. Common Stock (BCAX)vs ›

$1.14B

N/A

Harrow Health, Inc. (HROW)vs ›

$1.14B

1.60x

1.00x

0.57x

0.46x

GoodRx Holdings, Inc. (GDRX)vs ›

$1.16B

2.05x

1.65x

1.11x

0.98x

Teladoc Health, Inc. (TDOC)vs ›

$1.05B

-13.34x

N/A

Avalyn Pharma Inc. Common Stock (AVLN)vs ›

$1.20B

N/A

Immatics N.V. (IMTX)vs ›

$1.04B

-192.41x

28.86x

Integra LifeSciences Holdings Corporation (IART)vs ›

$1.03B

0.79x

0.59x

2.04x

2.37x

Interest Coverage Ratio FAQ

What is the interest coverage ratio for Amphastar Pharmaceuticals, Inc. (AMPH)?

The interest coverage ratio for AMPH stock is 5.51x.

Is Amphastar Pharmaceuticals, Inc.'s interest coverage ratio high or low?

The interest coverage ratio of 5.51x is 81% below its 5-year average of 28.44x, near the low end of its 5-year range (2.08x–144.36x).

What is the TTM average interest coverage ratio for Amphastar Pharmaceuticals, Inc. (AMPH)?

The TTM average interest coverage ratio for AMPH stock is 4.83x.

What is the 3Y average interest coverage ratio for Amphastar Pharmaceuticals, Inc. (AMPH)?

The 3Y average interest coverage ratio for AMPH stock is 6.05x.

What is the 5Y average interest coverage ratio for Amphastar Pharmaceuticals, Inc. (AMPH)?

The 5Y average interest coverage ratio for AMPH stock is 28.44x.

What is the 10Y average interest coverage ratio for Amphastar Pharmaceuticals, Inc. (AMPH)?

The 10Y average interest coverage ratio for AMPH stock is 25.89x.

DATE	INTEREST COVERAGE RATIO
2026-06-30	5.97x
2026-03-31	2.08x
2025-12-31	5.37x
2025-09-30	4.03x
2025-06-30	6.72x
2025-03-31	5.93x
2024-12-31	7.03x
2024-09-30	8.52x
2024-06-30	6.41x
2024-03-31	5.58x
2023-12-31	5.71x
2023-09-30	5.30x
2023-06-30	10.24x
2023-03-31	84.00x
2022-12-31	71.65x
2022-09-30	41.04x
2022-06-30	62.53x
2022-03-31	60.88x
2021-12-31	144.36x
2021-09-30	47.00x
2021-06-30	122.79x
2021-03-31	99.10x
2020-12-31	32.72x
2020-09-30	20.10x
2020-06-30	-83.49x
2020-03-31	98.42x
2019-12-31	-5.67x
2019-09-30	109.27x
2019-06-30	40.54x
2019-03-31	-105.73x
2018-12-31	1545.00x
2018-09-30	20.56x
2018-06-30	-28.57x
2018-03-31	-551.00x
2017-12-31	-12.42x
2017-09-30	-10.68x
2017-06-30	9.22x
2017-03-31	7.35x
2016-12-31	-83.52x
2016-09-30	20.63x
2016-06-30	33.87x
2016-03-31	10.61x
2015-12-31	70.45x
2015-09-30	-16.16x
2015-06-30	-48.86x
2015-03-31	-21.29x
2014-09-30	-15.51x
2014-06-30	-2.46x
2014-03-31	-10.94x
2013-12-31	13.26x
2013-09-30	1.16x
2013-06-30	50.56x
2013-03-31	7.71x

DATE

INTEREST COVERAGE RATIO

2026-06-30

5.97x

2026-03-31

2.08x

2025-12-31

5.37x

2025-09-30

4.03x

2025-06-30

6.72x

2025-03-31

5.93x

2024-12-31

7.03x

2024-09-30

8.52x

2024-06-30

6.41x

2024-03-31

5.58x

2023-12-31

5.71x

2023-09-30

5.30x

2023-06-30

10.24x

2023-03-31

84.00x

2022-12-31

71.65x

2022-09-30

41.04x

2022-06-30

62.53x

2022-03-31

60.88x

2021-12-31

144.36x

2021-09-30

47.00x

2021-06-30

122.79x

2021-03-31

99.10x

2020-12-31

32.72x

2020-09-30

20.10x

2020-06-30

-83.49x

2020-03-31

98.42x

2019-12-31

-5.67x

2019-09-30

109.27x

2019-06-30

40.54x

2019-03-31

-105.73x

2018-12-31

1545.00x

2018-09-30

20.56x

2018-06-30

-28.57x

2018-03-31

-551.00x

2017-12-31

-12.42x

2017-09-30

-10.68x

2017-06-30

9.22x

2017-03-31

7.35x

2016-12-31

-83.52x

2016-09-30

20.63x

2016-06-30

33.87x

2016-03-31

10.61x

2015-12-31

70.45x

2015-09-30

-16.16x

2015-06-30

-48.86x

2015-03-31

-21.29x

2014-09-30

-15.51x

2014-06-30

-2.46x

2014-03-31

-10.94x

2013-12-31

13.26x

2013-09-30

1.16x

2013-06-30

50.56x

2013-03-31

7.71x

Interest Coverage Ratio: 5.51x

AMPH Interest Coverage Ratio

AMPH Average Interest Coverage Ratio Chart

AMPH Current vs Average Interest Coverage Ratio Chart

AMPH Interest Coverage Ratio Metrics

AMPH Competitors' Interest Coverage Ratio

Financial Health Indicators

Interest Coverage Ratio Formula & Definition

Interest Coverage Ratio FAQ

AMPH Interest Coverage Ratio History

Related Metrics